Related references
Note: Only part of the references are listed.CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Wen-Hsuan Wu et al.
MOLECULAR THERAPY (2022)
Dual-AAV delivering split prime editor system for in vivo genome editing
Shengyao Zhi et al.
MOLECULAR THERAPY (2022)
In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration
Elliot H. Choi et al.
NATURE COMMUNICATIONS (2022)
CRISPR/Cas therapeutic strategies for autosomal dominant disorders
Salvatore Marco Caruso et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing
Susie Suh et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Kalyan Dulla et al.
MOLECULAR THERAPY (2021)
Prime Editing for Inherited Retinal Diseases
Bruna Lopes da Costa et al.
FRONTIERS IN GENOME EDITING (2021)
Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid
Adrian M. Timmers et al.
HUMAN GENE THERAPY (2020)
Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs
Mark J. Osborn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
CRISPR-Cas12-based detection of SARS-CoV-2
James P. Broughton et al.
NATURE BIOTECHNOLOGY (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
Da Meng et al.
MOLECULAR THERAPY (2020)
Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
Jun Young Park et al.
FRONTIERS IN NEUROSCIENCE (2020)
CasX enzymes comprise a distinct family of RNA-guided genome editors (vol 566, pg 218, 2019)
Jun-Jie Liu et al.
NATURE (2019)
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
Albert M. Maguire et al.
OPHTHALMOLOGY (2019)
Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect
Artur V. Cideciyan et al.
NATURE MEDICINE (2019)
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Morgan L. Maeder et al.
NATURE MEDICINE (2019)
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Ronald A. M. Buijsen et al.
NEUROTHERAPEUTICS (2019)
Ophthalmic features of spinocerebellar ataxia type 7
A. Campos-Romo et al.
EYE (2018)
Gene Therapy Using a miniCEP290 Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis
Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Non-syndromic retinitis pigmentosa
Sanne K. Verbakel et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Seeing the Light after 25 Years of Retinal Gene Therapy
Ivana Trapani et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Jacque L. Duncan et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2018)
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
Kalyan Dulla et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
Lukas Villiger et al.
NATURE MEDICINE (2018)
In utero CRISPR-mediated therapeutic editing of metabolic genes
Avery C. Rossidis et al.
NATURE MEDICINE (2018)
Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7
Chenchen Niu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Preena Tanna et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Guo-Xiang Ruan et al.
MOLECULAR THERAPY (2017)
RNA targeting with CRISPR-Cas13
Omar O. Abudayyeh et al.
NATURE (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Polyglutamine spinocerebellar ataxias - from genes to potential treatments
Henry L. Paulson et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
Jesse D. Sengillo et al.
GENES (2017)
CRISPR applications in ophthalmologic PINION genome surgery
Thiago Cabral et al.
CURRENT OPINION IN OPHTHALMOLOGY (2017)
A review of the mechanisms of cone degeneration in retinitis pigmentosa
Daniel S. Narayan et al.
ACTA OPHTHALMOLOGICA (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis
J. W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Xiao-Hui Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration
Susan F. Murray et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Nonallele Specific Silencing of Ataxin-7 Improves Disease Phenotypes in a Mouse Model of SCA7
Pavitra S. Ramachandran et al.
MOLECULAR THERAPY (2014)
Vector platforms for gene therapy of inherited retinopathies
Ivana Trapani et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2014)
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Steven Lin et al.
ELIFE (2014)
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Efficacy of Codelivery of Dual AAV2/5 Vectors in the Murine Retina and Hippocampus
Arpad Palfi et al.
HUMAN GENE THERAPY (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Genetic therapies for RNA mis-splicing diseases
Suzan M. Hammond et al.
TRENDS IN GENETICS (2011)
A look at autoimmunity and inflammation in the eye
Rachel R. Caspi
JOURNAL OF CLINICAL INVESTIGATION (2010)
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
Yi Lai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
RNA interference-mediated suppression and replacement of human rhodopsin in vivo
Mary O'Reilly et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery
M. Gorbatyuk et al.
VISION RESEARCH (2007)
Mutations Other Than Null Mutations Producing a Pathogenic Loss of Progranulin in Frontotemporal Dementia
Julie van der Zee et al.
HUMAN MUTATION (2007)
An eye's view of T regulatory cells
Joan Stein-Streilein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Effective gene therapy with nonintegrating lentiviral vectors
RJ Yáñez-Muñoz et al.
NATURE MEDICINE (2006)
Molecular pathogenesis of spinocerebellar ataxias
Antoni Matilla Duenas et al.
BRAIN (2006)
Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II
E van Wijk et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Spinocerebellar ataxia 7 (SCA7)
AS Lebre et al.
CYTOGENETIC AND GENOME RESEARCH (2003)